Correlation Between IShares Canadian and Cipher Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Canadian and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Canadian and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Canadian HYBrid and Cipher Pharmaceuticals, you can compare the effects of market volatilities on IShares Canadian and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Canadian with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Canadian and Cipher Pharmaceuticals.

Diversification Opportunities for IShares Canadian and Cipher Pharmaceuticals

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between IShares and Cipher is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding iShares Canadian HYBrid and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and IShares Canadian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Canadian HYBrid are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of IShares Canadian i.e., IShares Canadian and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between IShares Canadian and Cipher Pharmaceuticals

Assuming the 90 days trading horizon iShares Canadian HYBrid is expected to generate 0.07 times more return on investment than Cipher Pharmaceuticals. However, iShares Canadian HYBrid is 15.26 times less risky than Cipher Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  1,953  in iShares Canadian HYBrid on August 29, 2024 and sell it today you would earn a total of  11.00  from holding iShares Canadian HYBrid or generate 0.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

iShares Canadian HYBrid  vs.  Cipher Pharmaceuticals

 Performance 
       Timeline  
iShares Canadian HYBrid 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Canadian HYBrid are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental drivers, IShares Canadian is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Cipher Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

IShares Canadian and Cipher Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Canadian and Cipher Pharmaceuticals

The main advantage of trading using opposite IShares Canadian and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Canadian position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.
The idea behind iShares Canadian HYBrid and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios